Upload
Featured Recent Articles Topics Login Upload

Search Results for 'fda disease'

fda disease published presentations and documents on DocSlides.

MARCH 30, 2021 Outpatient COVID-19 Therapy as an
MARCH 30, 2021 Outpatient COVID-19 Therapy as an
by jaena
Inpatient Surge Mitigator. John T. Redd, MD, MPH, ...
x0000x0000 xMCIxD 0 xMCIxD 0 Guidance for Industry2 xMCIxD
x0000x0000 xMCIxD 0 xMCIxD 0 Guidance for Industry2 xMCIxD
by smith
cdsnascderguid6019dftdoc 01/23/04 Draft 151 Not fo...
Should I Use a DCB (Drug Coated Balloon) Here?
Should I Use a DCB (Drug Coated Balloon) Here?
by mackenzie
Brandon M. Jones, MD. Interventional Cardiology. P...
David Feldman, Ph.D., National Kidney Foundation
David Feldman, Ph.D., National Kidney Foundation
by madison
James Valentine, J.D., M.H.S., Meeting Moderator. ...
Gene Therapy and Genome Editing Technology
Gene Therapy and Genome Editing Technology
by samantha
Peter Marks, MD, PhD. National Press Foundation. N...
Scott Gottlieb MD
Scott Gottlieb MD
by eliza
1 October 10, 2018 Commissioner Food and Drug Admi...
Using Monoclonal Antibodies in LTC
Using Monoclonal Antibodies in LTC
by ethlyn
David A. Nace, MD, MPH, CMD. Associate Professor o...
The Rare Disease Treatment Approval Process:
The Rare Disease Treatment Approval Process:
by lily
Balancing Gold Standard Evidence with Patient-Cent...
PatientFocusedDevelopment
PatientFocusedDevelopment
by evelyn
MeetingMeetingOctoberTheresaPhDAssociateDirectorfo...
x0000x0000 xAttxachexd xBottxom xBBoxx 2x569x83 3x477x15 6x019x8 62
x0000x0000 xAttxachexd xBottxom xBBoxx 2x569x83 3x477x15 6x019x8 62
by susan
Idiopathic Thrombocytopenic PurpuraJune 26 2019May...
Can I Make an App for That?
Can I Make an App for That?
by mitsue-stanley
How FDA and HIPAA regulations apply to medical mo...
Fecal Microbiota Transplant
Fecal Microbiota Transplant
by liane-varnes
Success, Challenges,. and the FDA. Cheryl Griesba...
The DMO:
The DMO:
by trish-goza
Improving the Quality, Quickness. and Quantity of...
Improving the process of rare disease treatment development
Improving the process of rare disease treatment development
by lindy-dunigan
“. EMERGING THERAPIES FOR RARE DISEASES. ”. ...
Heart Disease
Heart Disease
by liane-varnes
The Myths, Facts & Causes,. . Prevention, Tr...
Extrapolation in Pediatric Drug Development: An Evolving Science
Extrapolation in Pediatric Drug Development: An Evolving Science
by briana-ranney
Lynne P. Yao, M.D.. Director, Division of Pediatr...
Pazopanib Interactions with FDA
Pazopanib Interactions with FDA
by claire
Office of Commissioner. Center for Drug. Evaulatio...
Immuneresponsetoenzymereplacementtherapiesinlysosomalstoragediseasesan
Immuneresponsetoenzymereplacementtherapiesinlysosomalstoragediseasesan
by iris
   Abbreviations: Ab, antibody; AD...
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
by morton
Center for Preparedness and Response What Clinicia...
COVID 19 Vaccine Educational Brief
COVID 19 Vaccine Educational Brief
by summer
Kevin E Mackey MD, FAEMS. Sacramento Regional Fire...
Issues of public health, infectious diseases and bioterrorism
Issues of public health, infectious diseases and bioterrorism
by iris
The role of public health in the prevention of inf...
NEWS FROM NORD
NEWS FROM NORD
by hoodrona
careg...
Passion is our driver, strategy is our compass
Passion is our driver, strategy is our compass
by briana-ranney
May 6, 2016. Family Introductions. Proposed juv...
Steven Taylor Chief Executive Officer
Steven Taylor Chief Executive Officer
by liane-varnes
Sjögren’s Syndrome Foundation. www.sjogrens.or...
Our Designer Future:
Our Designer Future:
by celsa-spraggs
How . FDA Legal Issues Shape Human Health. –. F...
Debate 1: Short term trials with surrogate outcomes in diab
Debate 1: Short term trials with surrogate outcomes in diab
by olivia-moreira
Group 6. Most common types of diabetes. Type 1. P...
U.S. Federal Patent
U.S. Federal Patent
by liane-varnes
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=P...
Duchenne Parent Project.NL /PPMD . USA
Duchenne Parent Project.NL /PPMD . USA
by natalia-silvester
. Orlando, Florida 1994. Basic Principles:. As...
Fad Diets & Dietary Supplements
Fad Diets & Dietary Supplements
by alexa-scheidler
WHAT DO I NEED TO KNOW. Fad Diets. Americans spen...
United Spinal Association
United Spinal Association
by alida-meadow
August, 2014. Biologics & Biosimilars: . An O...
Clinical Investigator Training Course
Clinical Investigator Training Course
by luanne-stotts
Issues in Clinical Trial Design for Rare Diseases...
Applying Science to Improve the Individualized Treatment of Patients with Psoriasis
Applying Science to Improve the Individualized Treatment of Patients with Psoriasis
by thesoysi
Abrar Qureshi, MD, MPH. Chief of the Department of...
Report Adverse events including problems with test performance or resu
Report Adverse events including problems with test performance or resu
by oryan
1 PageFACT SHEET FOR HEALTHCARE PROVIDERSCoronavir...
Dova Pharmaceuticals Announces FDA Approval of Supplemental
Dova Pharmaceuticals Announces FDA Approval of Supplemental
by ani
New Drug Application for DOPTELETavatrombopag for ...
Where can I go for updates and more informationhe most update informa
Where can I go for updates and more informationhe most update informa
by sophia2
COVIDis available at theGeneral webpagehttps://www...
Striking the Balance: FDA Oncology’s Regulatory Perspective on Development of Agents for CIPN
Striking the Balance: FDA Oncology’s Regulatory Perspective on Development of Agents for CIPN
by rodriguez
Lynn Howie, MD, Medical Officer, DOP1. Supportive ...